# Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

> **NCT04882007** · PHASE2 · COMPLETED · sponsor: **OSE Immunotherapeutics** · enrollment: 136 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** OSE-127
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04882007
- **Lead sponsor:** OSE Immunotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-02
- **Primary completion:** 2024-04-30
- **Final completion:** 2025-01-28
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04882007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04882007, "Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04882007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*